Skip to content

Clinical trials

Idiopathic Pulmonary Fibrosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Country / region: Australia Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20092
20101
20122
20134
20152
20162
20171
20182
20192
20204
20214
20227
20237
20249
20253
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated15
Active, not recruiting7
Recruiting7
Unknown status3
Not yet recruiting2
Withdrawn1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim9
Bristol-Myers Squibb4
Endeavor Biomedicines, Inc.4
Gilead Sciences3
Hoffmann-La Roche3
Avalyn Pharma Inc.2
Kyntra Bio2
Pliant Therapeutics, Inc.2
United Therapeutics2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis64
Pulmonary Fibrosis13
Lung Diseases, Interstitial10
Idiopathic Interstitial Pneumonias4
Fibrosis3
Cough2
Asthma1
Bronchiectasis1
Connective Tissue Diseases1
Cystic Fibrosis1

Trials

Showing 51 to 64 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.